Congress Revives Talks On LDTs With Clock Ticking On FDA Rule

While lawmakers continue to debate how LDTs should be regulated, the FDA’s proposed rule is fast approaching

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.